Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Lnp023
2. 1644670-37-0
3. Lnp-023
4. Iptacopan [inn]
5. Iptacopan [usan]
6. Nvp-lnp023-nx
7. Nvp-lnp023
8. 8e05t07z6w
9. 4-[(2s,4s)-4-ethoxy-1-[(5-methoxy-7-methyl-1h-indol-4-yl)methyl]piperidin-2-yl]benzoic Acid
10. 4-[(2~{s},4~{s})-4-ethoxy-1-[(5-methoxy-7-methyl-1~{h}-indol-4-yl)methyl]piperidin-2-yl]benzoic Acid
11. Benzoic Acid, 4-((2s,4s)-4-ethoxy-1-((5-methoxy-7-methyl-1h-indol-4-yl)methyl)-2-piperidinyl)-
12. Benzoic Acid, 4-[(2s,4s)-4-ethoxy-1-[(5-methoxy-7-methyl-1h-indol-4-yl)methyl]-2-piperidinyl]-
13. Iptacopan [who-dd]
14. Unii-8e05t07z6w
15. Chembl4594448
16. Schembl16400416
17. Gtpl10710
18. Us9682968, Example-26a
19. Bdbm160475
20. Ex-a5728
21. Who 11259
22. Zinc223246892
23. At30389
24. Compound 41 [pmid: 32073845]
25. Hy-127105
26. Cs-0093107
27. A935227
28. 4-((2s,4s)-(4-ethoxy-1-((5-methoxy-7-methyl-1h-indol-4-yl)methyl)piperidin-2-yl))benzoic Acid
29. 4-((2s,4s)-4-ethoxy-1-((5-methoxy-7-methyl-1h-indol-4-yl)methyl)piperidin-2-yl)benzoicacid
30. Jgq
Molecular Weight | 422.5 g/mol |
---|---|
Molecular Formula | C25H30N2O4 |
XLogP3 | 1.8 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 5 |
Rotatable Bond Count | 7 |
Exact Mass | 422.22055744 g/mol |
Monoisotopic Mass | 422.22055744 g/mol |
Topological Polar Surface Area | 74.8 Ų |
Heavy Atom Count | 31 |
Formal Charge | 0 |
Complexity | 594 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 2 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Patents & EXCLUSIVITIES
Patent Expiration Date : 2038-08-30
US Patent Number : 11723901
Drug Substance Claim :
Drug Product Claim :
Application Number : 218276
Patent Use Code : U-3980
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2038-08-30
Patent Expiration Date : 2034-07-14
US Patent Number : 10093663
Drug Substance Claim :
Drug Product Claim :
Application Number : 218276
Patent Use Code : U-3980
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2034-07-14
Patent Expiration Date : 2041-05-25
US Patent Number : 11603363
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 218276
Patent Use Code :
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2041-05-25
Patent Expiration Date : 2041-07-15
US Patent Number : 11951101
Drug Substance Claim :
Drug Product Claim :
Application Number : 218276
Patent Use Code : U-3895
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2041-07-15
Exclusivity Code : NCE
Exclusivity Expiration Date : 2028-12-05
Application Number : 218276
Product Number : 1
Exclusivity Details :
Exclusivity Code : ODE-456
Exclusivity Expiration Date : 2030-12-05
Application Number : 218276
Product Number : 1
Exclusivity Details :
Exclusivity Code : I-949
Exclusivity Expiration Date : 2027-08-07
Application Number : 218276
Product Number : 1
Exclusivity Details :
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?